DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Nielsen TO, Parker JS, Leung S, Voduc D, Ebbert M, Vickery T et al
A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer.
Clin Cancer Res 2010;
16(21): 5222-5232
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.